Suanfarma Suanfarma

X

Find Remibrutinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Remibrutinib
Also known as: 1787294-07-8, Remibrutinib [inn], Lou064, Remibrutinib [usan], I7mvz8hdnu, Remibrutinib (lou064)
Molecular Formula
C27H27F2N5O3
Molecular Weight
507.5  g/mol
InChI Key
CUABMPOJOBCXJI-UHFFFAOYSA-N
FDA UNII
I7MVZ8HDNU

1 2D Structure

Remibrutinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[3-[6-amino-5-[2-[methyl(prop-2-enoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide
2.1.2 InChI
InChI=1S/C27H27F2N5O3/c1-4-23(35)34(3)9-10-37-25-24(31-14-32-26(25)30)20-12-18(28)13-22(15(20)2)33-27(36)19-8-7-17(11-21(19)29)16-5-6-16/h4,7-8,11-14,16H,1,5-6,9-10H2,2-3H3,(H,33,36)(H2,30,31,32)
2.1.3 InChI Key
CUABMPOJOBCXJI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C
2.2 Other Identifiers
2.2.1 UNII
I7MVZ8HDNU
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Lou064

2. N-(3-(6-amino-5-(2-(methyl(prop-2-enoyl)amino)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide

2.3.2 Depositor-Supplied Synonyms

1. 1787294-07-8

2. Remibrutinib [inn]

3. Lou064

4. Remibrutinib [usan]

5. I7mvz8hdnu

6. Remibrutinib (lou064)

7. Nvp-lou064-nxa

8. Lou064-nxa

9. N-(3-(6-amino-5-(2-(n-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide

10. N-[3-[6-amino-5-[2-[methyl(1-oxo-2-propen-1-yl)amino]ethoxy]-4-pyrimidinyl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide

11. N-[3-[6-amino-5-[2-[methyl(prop-2-enoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide

12. Benzamide, N-(3-(6-amino-5-(2-(methyl(1-oxo-2-propen-1-yl)amino)ethoxy)-4-pyrimidinyl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluoro-

13. Unii-i7mvz8hdnu

14. Chembl4483575

15. Schembl16754888

16. Gtpl10457

17. Lou-064

18. Ex-a3421

19. S9660

20. Who 11062

21. Example 6 [wo2015079417a1]

22. Compound 25 [pmid: 32083858]

23. Ac-36985

24. Hy-128757

25. Cs-0103905

26. Us9512084, 6

27. A930622

28. Lou-064;n-(3-(6-amino-5-(2-(n-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide

2.4 Create Date
2016-02-23
3 Chemical and Physical Properties
Molecular Weight 507.5 g/mol
Molecular Formula C27H27F2N5O3
XLogP33.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count9
Exact Mass507.20819606 g/mol
Monoisotopic Mass507.20819606 g/mol
Topological Polar Surface Area110 Ų
Heavy Atom Count37
Formal Charge0
Complexity815
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Protein Kinase Inhibitors

Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY